BlackRock, Inc. 13D and 13G filings for Vanda Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-07 1:40 pm Sale |
2025-01-31 | 13G | Vanda Pharmaceuticals Inc. VNDA |
BlackRock Inc. BLK |
4,699,280 8.100% |
-4,404,924 (-48.38%) |
Filing |
| 2025-02-05 1:23 pm Purchase |
2024-12-31 | 13G | Vanda Pharmaceuticals Inc. VNDA |
BlackRock Inc. BLK |
9,104,204 15.600% |
757,837 (+9.08%) |
Filing |
| 2024-01-23 11:52 am Purchase |
2023-12-31 | 13G | Vanda Pharmaceuticals Inc. VNDA |
BlackRock Inc. BLK |
8,346,367 14.500% |
1,587,250 (+23.48%) |
Filing |
| 2023-10-06 2:34 pm Sale |
2023-09-30 | 13G | Vanda Pharmaceuticals Inc. VNDA |
BlackRock Inc. BLK |
6,759,117 11.800% |
-3,567,497 (-34.55%) |
Filing |
| 2023-01-24 1:56 pm Purchase |
2022-12-31 | 13G | Vanda Pharmaceuticals Inc. VNDA |
BlackRock Inc. BLK |
10,326,614 18.200% |
501,239 (+5.10%) |
Filing |
| 2022-01-27 5:14 pm Unchanged |
2021-12-31 | 13G | Vanda Pharmaceuticals Inc. VNDA |
BlackRock Inc. BLK |
9,825,375 17.600% |
0 (Unchanged) |
Filing |
| 2022-01-26 09:17 am Purchase |
2021-12-31 | 13G | Vanda Pharmaceuticals Inc. VNDA |
BlackRock Inc. BLK |
9,825,375 17.600% |
10,778 (+0.11%) |
Filing |
| 2021-01-25 4:49 pm Purchase |
2020-12-31 | 13G | Vanda Pharmaceuticals Inc. VNDA |
BlackRock Inc. BLK |
9,814,597 17.900% |
428,716 (+4.57%) |
Filing |